Abstract
In Bolzano province 84,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering local tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 7 cases of cervicocarcinoma and 3 related deaths and thus results to be cost-effective (40.541 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 6 cancer cases and 3 deaths could be prevented, with a very similar cost-effectiveness ratio. In Bolzano province, the net cost for woman vaccinated is 216 € for the single cohort and 218 € for the multiple cohort.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have